Lensar Overview
- Year Founded
-
2004
- Status
-
Public
- Employees
-
150
- Stock Symbol
-
LNSR
- Investments
-
1
- Share Price
-
$4.49
- (As of Friday Closing)
Lensar General Information
Description
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.
Contact Information
Website
www.lensar.comCorporate Office
- 2800 Discovery Drive
- Orlando, FL 32826
- United States
Corporate Office
- 2800 Discovery Drive
- Orlando, FL 32826
- United States
Lensar Stock Performance
As of 20-Nov-2026, Lensar’s stock price is $4.49. Its current market cap is $55.1M with 12.3M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $4.49 | $4.65 | $4.30 - $12.94 | $55.1M | 12.3M | 68.3K | $1.31 |
Lensar Financials Summary
As of 30-Sep-2026, Lensar has a trailing 12-month revenue of $60.1M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 83,564 | 138,710 | 101,433 | 30,756 |
| Revenue | 60,079 | 58,435 | 53,494 | 42,164 |
| EBITDA | 38,115 | (29,778) | (27,473) | (10,868) |
| Net Income | 33,686 | (34,280) | (31,404) | (14,383) |
| Total Assets | 67,068 | 71,430 | 66,297 | 69,585 |
| Total Debt | 2,186 | 2,735 | 2,614 | 2,309 |
Lensar Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Lensar Patents
Lensar Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023233605-A1 | Systems and methods for determining the characteristics of structures of the eye including shape and positions | Inactive | 17-Mar-2022 | ||
| AU-2026205548-A1 | Systems and methods for determining the characteristics of structures of the eye including shape and positions | Pending | 17-Mar-2022 | ||
| EP-4493092-A1 | Systems and methods for determining the characteristics of structures of the eye including shape and positions | Pending | 17-Mar-2022 | ||
| EP-4493092-A4 | Systems and methods for determining the characteristics of structures of the eye including shape and positions | Pending | 17-Mar-2022 | ||
| US-20230329909-A1 | Systems and methods for determining the characteristics of structures of the eye including shape and positions | Pending | 17-Mar-2022 | A61F9/008 |
Lensar Signals
Lensar Acquisitions (1)
Lensar’s most recent deal was a Merger/Acquisition with Precision Eye Services (laser business unit). The deal was made on 11-Jan-2018.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Precision Eye Services (laser business unit) | 11-Jan-2018 | Merger/Acquisition | Surgical Devices |
Lensar ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
33.34 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Devices
Subindustry
of 209
Rank
Percentile
Lensar FAQs
-
When was Lensar founded?
Lensar was founded in 2004.
-
Where is Lensar headquartered?
Lensar is headquartered in Orlando, FL.
-
What is the size of Lensar?
Lensar has 150 total employees.
-
What industry is Lensar in?
Lensar’s primary industry is Other Devices and Supplies.
-
Is Lensar a private or public company?
Lensar is a Public company.
-
What is Lensar’s stock symbol?
The ticker symbol for Lensar is LNSR.
-
What is the current stock price of Lensar?
As of 20-Nov-2026 the stock price of Lensar is $4.49.
-
What is the current market cap of Lensar?
The current market capitalization of Lensar is $55.1M.
-
What is Lensar’s current revenue?
The trailing twelve month revenue for Lensar is $60.1M.
-
What is Lensar’s annual earnings per share (EPS)?
Lensar’s EPS for 12 months was $1.31.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process